Catalyst Wire Dossier Catalyst Wire Dossier

RCI001 Ophthalmic Solution

RCI001 · ORA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RCI001 Ophthalmic Solution, covering 2025-07-16 to 2025-07-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye [Phase 2]

See pricing